Comparison of incadronate and alfacalcidol on increased bone turnover caused by ovariectomy in rats

European Journal of Pharmacology

Volumn 449, Issue 1-2, 2002, Pages 191-196

  Teramura, Kyoko ^a   Fukushima, Shinji ^a   Nozaki, Kazutoshi ^a   Kokubo, Satoshi ^a,b   Takahashi, Koichiro ^a  

^a Applied Pharmacology Laboratories   (Japan)

^b ASTELLAS PHARMA INC   (Japan)

Author keywords

Bisphosphonate; Bone mineral density; Deoxypyridinoline; Osteoporosis; Ovariectomy

Indexed keywords

ALFACALCIDOL; CALCIUM ION; DEOXYPYRIDINOLINE; INCADRONIC ACID; PARATHYROID HORMONE; 1-HYDROXYCHOLECALCIFEROL; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; HYDROXYCOLECALCIFEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MASS; BONE MINERAL; BONE TURNOVER; CALCIUM BLOOD LEVEL; CALCIUM EXCRETION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSE CALCULATION; DOSE RESPONSE; DRUG MECHANISM; FEMALE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; METAPHYSIS; NONHUMAN; OSTEOLYSIS; OVARIECTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; TRABECULAR BONE; URINE LEVEL; ANIMAL; BLOOD; BONE; COMPARATIVE STUDY; DRUG EFFECT; METABOLISM; RADIOGRAPHY; SPRAGUE DAWLEY RAT; TIBIA; URINE;

ANIMAL; BONE AND BONES; BONE DENSITY; CALCIUM; COMPARATIVE STUDY; DIPHOSPHONATES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HYDROXYCHOLECALCIFEROLS; OVARIECTOMY; PARATHYROID HORMONES; RATS; RATS, SPRAGUE-DAWLEY; TIBIA; TOMOGRAPHY, X-RAY COMPUTED; ANIMALS; PARATHYROID HORMONE;

EID: 0037008270     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)01979-9     Document Type: Article

References (31)

1. Comparative studies of actions of bisphosphonates on bone resorption in vitro
2. Long-term treatment with calcitriol in postmenopausal osteoporosis
3. 3 and calcium to prevent hip fractures in elderly women
4. 3 treatment decreases bone turnover and modulates calcium-regulating hormones in early postmenopausal women
5. Oral 1,25-dihydroxyvitamin D administration in osteoporotic women: Effects of estrogen therapy
6. 1,25-Dihydroxyvitamin D stimulation test for osteoblast function in normal and osteoporotic postmenopausal women
7. Effect of disodium dihydrogen (cycloheptylamino) methylene bisphosphonate monohydrate (YM175) on the bone formation and resorption in rats and dogs: Histological examination
8. 3: Short- and long-term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis
9. The effect of calcitriol on patients with postmenopausal osteoporosis with special reference to fracture frequency
10. Alendronate stimulation of nocturnal parathyroid hormone secretion: A mechanism to explain the continued improvement in bone mineral density accompanying alendronate therapy
11. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo
12. The ovariectomized rat model of postmenopausal bone loss
13. Pharmacological actions of the novel bisphosphonate YM175
14. Effect of YM175 on experimental hypercalcemia and tumor-induced osteolysis in rats
15. 3) and calcium in osteoporosis
16. Effects of the bisphosphonate YM175 on bone mineral density, strength, structure, and turnover in ovariectomized beagles on concomitant dietary calcium restriction
17. Prevention of bone loss by bisphosphonate YM175 in ovariectomized dogs with dietary calcium restriction
18. The effect of ovariectomy on bone metabolism in rats
19. Prevention of bone loss by vitamin D supplementation in elderly women: A randomized double-blind trial
20. 3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis
21. 1,25-Dihydroxycholecalciferol: A potent stimulator of bone resorption in tissue culture
22. Characteristics of clodronate-induced apoptosis in osteoclasts and macrophages
23. 3 in regulating parathyroid gland function
24. 3
25. 3 on bone mineral density and incidence of fracture: A placebo-controlled, double-blind prospective study
26. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients
27. Effects of YM175, a new-generation bisphosphonate, on hypercalcemia induced by tumor-derived bone resorbing factors in rats
28. Studies on novel bone resorption inhibitors: I. Synthesis and pharmacological activities of aminomethylene bisphosphonate derivatives
29. YM175 inhibits tumor-induced osteolysis in nude mice with bone metastases
30. Treatment of postmenopausal osteoporosis with calcitriol or calcium
31. Differential effects of menopause and metabolic disease on trabecular and cortical bone assessed by peripheral quantitative computed tomography (pQCT)